The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function

Curr Opin Nephrol Hypertens. 2012 Jan;21(1):7-14. doi: 10.1097/MNH.0b013e32834d9d75.

Abstract

Purpose of review: Cyclooxygenase-2 (COX-2) plays a critical role in modulating deleterious actions of angiotensin II (Ang II) where there is an inappropriate activation of the renin-angiotensin system (RAS). This review discusses the recent developments regarding the complex interactions by which COX-2 modulates the impact of an activated RAS on kidney function and blood pressure.

Recent findings: Normal rats with increased COX-2 activity but with different intrarenal Ang II activity because of sodium restriction or chronic treatment with angiotensin-converting enzyme (ACE) inhibitors showed similar renal hemodynamic responses to COX-2-selective inhibition (nimesulide) indicating independence from the intrarenal Ang II activity. COX-2-dependent maintenance of medullary blood flow was consistent and not dependent on dietary salt or ACE inhibition. In contrast, COX-2 influences on sodium excretion were contingent on the prevailing RAS activity. In chronic hypertensive models, COX-2 inhibition elicited similar reductions in kidney function, but COX-2 metabolites contribute to rather than ameliorate the hypertension.

Summary: The maintenance of renal hemodynamics reflects direct and opposing effects of Ang II and COX-2 metabolites. The antagonism in water and electrolyte reabsorption is dependent on the prevailing intrarenal Ang II activity. The recent functional experiments demonstrate a beneficial modulation of Ang II by COX-2 except in the presence of inflammation promoted by hypertension, hyperglycemia, and oxidative stress.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Angiotensin II / metabolism*
  • Animals
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / therapeutic use
  • Humans
  • Hypertension / drug therapy
  • Hypertension / enzymology*
  • Hypertension / etiology
  • Hypertension / physiopathology
  • Kidney / drug effects
  • Kidney / enzymology*
  • Kidney / physiopathology
  • Kidney Diseases / complications
  • Kidney Diseases / drug therapy
  • Kidney Diseases / enzymology*
  • Kidney Diseases / physiopathology
  • Renin-Angiotensin System* / drug effects
  • Signal Transduction

Substances

  • Antihypertensive Agents
  • Cyclooxygenase 2 Inhibitors
  • Angiotensin II
  • Cyclooxygenase 2